MaxCyte (MXCT) Stock News
$MXCT · NASDAQ · 3 stories in 30 daysBORSA has published 3 stories on MaxCyte (MXCT) in the past 30 days. BORSA’s news read on MXCT is leaning bullish at 53/100, unchanged over 24 hours, based on 3 company events over the past 30 days. MaxCyte’s next earnings report is scheduled for Wednesday, Nov 11.
The wire on $MXCT
newest first · updated · direct subject stories onlyKapileshwar joins MaxCyte from Danaher Corp
Kapileshwar, previously at Danaher Corp, has joined MaxCyte. The move adds Danaher experience to MaxCyte's leadership.
bullish 65 · impact 30MaxCyte Names Sidharth Kapileshwar Chief Corporate Development Officer
MaxCyte has appointed Sidharth Kapileshwar as chief corporate development officer.
neutral 50 · impact 10